Abstract
IntroductIon
Chronic periprosthetic joint infections (PJI) have received increasing interest in the medical literature as the pro fession has acknowledged the reallife implications to the patient and the health service [1, 2] . The treatment of PJI is costly to the health service with strain upon limited resources as multiple operations and trials of antibiotic therapy may be attempted. But the cost to the patient is greatest, with loss or reduced joint function, deterioration in their physical and psychological health, and loss in trust with the profession.
Prevention is key. Despite improved outcomes following the various treatment modalities for treating established infections today, the patient has to endure the con sequences of the infection [3] . Prior to the initial surgery it is imperative the patient is medically optimised and any reversible risk factors be corrected. Such risk factors are well known such as diabetes [4] , systemic infections [5] , and immunocompromise [6] . However, risk factors vary and are dependent upon the patient cohort, and often findings from isolated studies are not transferable. Therefore, we undertook a systematic review of the literature to determine over all predictive factors that increase a patient's risk of developing a lower limb PJI, and determine which risk factors are most predictive of infection.
In this review, we categorised risk factors in order to better understand the relative role of the host, of the healthcare provider, and of postsurgical conditions, the latter acting more as prognostic factors since the surgical procedure has already taken place. To this aim, we have subdivided known risk factors for PJI in three groups: (1) those relating to the host (hostrelated risk factors); (2) those that are related to the treatment provider and to the surgical environment (providerrelated risk factors); and (3) those that arise from clinical interventions, increasing the patient's inherent risk (postsurgical risk factors). We have then compared the absolute number of risk factors in each main category, scored them according to their relative weight and divided in "modifiable" and "non-modifiable" risk factors.
MAtErIALS And MEthodS
This systematic review included fulltext studies that reviewed risk factors of developing either a hip or knee PJI following a primary arthroplasty published from January 1998 to November 2016. These were identified through international databases, such as EMBASE, PubMed/ MEDLINE, MEDLINE Daily Update, MEDLINE InProcess, Google Scholar, SCOPUS, CINAHL, Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews.
A variety of keywords were used either alone or in combinations to identify the studies. This included re ferences to hip infections (total hip replacement; THR; periprosthetic hip infection, hip arthroplasty infection), knee infections (total knee replacement; TKR; periprosthetic knee infection, knee arthroplasty infection), general joint infections (PJI, PPI), and "risk factors". We did not use specific keywords to search for individual risk factors, such as diabetes, etc.
Studies were only included if the risk factors were calculated by involving greater than 20 patients in their study cohort, and there was clear documentation of the statistical parameter used, and were only included if the Pvalue was quoted and one or more of the following; hazard ratio (HR), relative risk (RR), or/and odds ratio. Studies were excluded if they referred to recurrent infection following a revision procedure, hip or knee fracture, and a risk factor was excluded if the pvalue was greater than 0.05. Results from combined studies, as seen in metaanalysis, were also excluded.
Two investigators, DAG and CLR, independently se arched and reviewed the literature and determined if the study should be included based on their title and abstract. Once the two lists were compared, if the same material was presented in more than one study, only the most recent one was included.
The quality assessment criteria for the inclusion of the individual studies was adapted from George et al [7] . to reflect the information we expect to be present in each study. Therefore we evaluated the presence of (1) record bias reflecting the source of data, and whether the analysis was retrospective or prospective; and (2) reporting bias; each study's definition of PJI (the measured outcome). Figure 1 demonstrates the overall selection process according to the Prisma model [8] . DAG, CLR, SS and EG compared the overall findings and any discrepancies were solved by reclassification as mutually agreed.
rESuLtS

Included studies
In all, 27 original studies reviewing risk factors relating to primary total hip and knee arthroplasty infections were included. The number of risk factors identified ranged from 1 to 18. Four studies (14.8%) reviewed PJI on the hip, 3 (11.21%) on the knee, and 20 (74.1%) reviewed both joints. The statistical methods used to determine significance are also shown in Table 1 [4, 5, 933] . The quality of the included studies is demonstrated in Table 2 . Nineteen studies (70.4%) were retrospective Berbari et al [9] 1998 462 462 924 OR, CI, P Both ---Lai et al [10] 2007 51 --OR, CI, P Both -84 -Parvizi et al [11] 2007 78 156 234 OR, CI, P Both ---Pulido et al [12] [14] 2009 887 39042 39929 OR, P Hip -108 -Berbari et al [5] 2010 339 339 678 OR, CI, P Both ---Peel et al [15] 2011 63 126 189 OR, CI, P Both ---Bozic et al [16] 2012 --40919 HR, CI, P Hip 12 --Jämsen et al [17] 2012 52 7129 7181 HR, CI, P Both 0 12 12 Bozic et al [4] 2012 --83011 OR, CI, P Knee 12 --Dale et al [18] 2012 2778 429390 432168 RR, CI, P Hip 0 60 60 Greenky et al [19] 2012 389 15333 15722 OR, CI, P Both 36 108 62.4 Namba et al [20] 2013 404 55812 56216 HR, CI, P Knee ---Somayaji et al [21] 2013 5 254 259 OR, CI, P Both 12 124 24 Coelho-Prabhu et al [22] 2013 339 339 678 OR, CI, P Both 2 24 -Maoz et al [23] 2014 47 3625 3672 OR, CI, P Hip 12 48 24 Gómez-Lesmes et al [24] 2014 32 1299 1331 OR, CI, P Knee -3 -Yi et al [25] 2014 126 375 501 OR, CI, P Both 3 --Wu et al [26] [28] 2014 --306946 HR, P Hip 6 --2014 --573840 HR, P Knee 6 --Duchman et al [29] 2015 8062+ 70129+ 78191 OR, CI, P Both ---Chrastil et al [30] 2015 --13272 HR, CI, P Both 24 120 -Crowe et al [31] 2015 26 3393 3419 OR, CI, P Both -12 -Debreuve-Theresette et al [32] 2015 45 90 OR, CI, P Both ---Bohl et al [33] positive culture result from one sample from the affected joint; and (Ⅵ) PMN leukocyte count of more than 5 per high-powered field in 5 high-powered fields on histologic analysis at 400 × magnification [34] .
Host-related risk factors
Risk factors relating to the host have been shown in Table 3 , and are the most abundant group of risk factors identified. The majority of the risk factors are systemic referring to patient comorbidities that are negatively associated with patient outcome following a primary THR or TKR, such as presence of diabetes mellitus [4, 9, 17, 20, 26] , immunocompromised [5, 15, 21] , concomitttent systemic infection [5, 10, 27, 31] , cardiology [4, 16, 21] and gastroenterology disorders [22, 28] , high ASA (American Society of Anesthesiologists) grade [12, 15, 20] and mal nutrition [13, 17, 21, 23, 25, 26, 33] . Patient demographics also have been shown to have an impact upon risk of PJI, including age [16] , rural residence [16] , race [20] , male gender [14, 18, 20, 31] , and alcohol [26] or tobacco use [23, 29, 31, 32] . Previous operations to the joint (excluding revisions arthroplasty as this was excluded from analysis) increased the risk of PJI [5, 32] . Berbari et al [9] Retrospective No 2 or more cultural examination positive for the same microorganism; sinus tract; purulence around the prosthesis/joint Lai et al [10] Retrospective No 2 or more cultural examination positive for the same microorganism; clinical diagnosis Parvizi et al [11] Prospective
No Criteria based upon 3 of 5 features 1 Pulido et al [12] Retrospective Yes Criteria based upon 3 of 5 features 1 Malinzak et al [13] Retrospective No Unknown Ong et al [14] Retrospective Yes Diagnostic code in Medicare database Berbari et al [5] Prospective Yes 2 or more cultural examination positive for the same microorganism; acute inflammation on histopathological examination; sinus tract; purulence around the prosthesis/joint Peel et al [15] Prospective Yes Criteria based upon 3 of 5 features 1 Bozic et al [16] Retrospective Yes Diagnostic code in Medicare database Jämsen et al [17] Prospective Yes CDC definition of surgical site infection 3 1 Bozic et al [4] Retrospective Yes Diagnostic code in Medicare database Dale et al [18] Retrospective Yes Clinical as reported by the surgeon after surgery Greenky et al [19] Retrospective
No Criteria based upon 3 of 5 features 1 Namba et al [20] Retrospective Yes CDC definition of surgical site infection 3 Somayaji et al [21] Retrospective No Criteria based upon 3 of 5 features 1
Coelho-Prabhu et al [22] Retrospective Yes 2 or more cultural examination positive for the same microorganism; sinus tract; purulence around the prosthesis/joint Maoz et al [23] Retrospective
Yes CDC definition of surgical site infection Gómez-Lesmes et al [24] Prospective Yes Criteria based upon 3 of 5 features 1
Yi et al [25] Retrospective No Criteria based upon 3 of 5 features 1 Wu et al [26] Retrospective Yes MSIS definition 2 Sousa et al [27] Retrospective No Criteria based upon 3 of 5 features 1 Jiang et al [28] Prospective Yes Diagnostic code in Medicare database Duchman et al [29] Prospective Yes Criteria based upon 3 of 5 features 1
Chrastil et al [30] Retrospective Yes Diagnostic code in Medicare database Crowe et al [31] Retrospective Yes CDC definition of surgical site infection 
Provider-related risk factors
Risk factors relating to the provider are shown in Table 4 . Prolonged operative duration of greater than 115 minutes in hip arthroplasty is a strong predictor of infection [5, 14, 23] , as is nonsame day surgery [23] . During knee arthroplasty, exposure to the joint requiring quadriceps release signi ficantly increases the risks of infection [20] . Protective measures include the use of antibiotic surgical prophylaxis systemically [5] and locally as irrigation [20] , but antibiotic impregnated cement may or may not be protective [18, 20] . In addition, bilateral procedures during the same operation have been shown by some studies to increase the risk [12] , whilst in others decrease it [20] .
Post-surgical risk factors
Postoperatively patients may present with a superficial infection to the joint with a warm, cellulitic, and sometimes discharging wound, which is a high predictor of an under lying PJI [5, 11, 9, 15] . Table 5 demonstrates other factors that have a high correlation with a PJI, including receiving a blood transfusion [11, 12, 15] (especially if the blood has been stored for greater than 14 d [24] ), postoperative urinary tract infection (UTI) [5, 12] , and onset of cardiac arrhythmias [12] .
Risk factor impact
Several risk factors were shown to have greater signi ficance than others, and a vast majority of the risk factors were directly related to the patient (hostfactors). The most significant risks were the use of preoperative high dose steroids (OR = 21.0, 95%CI: 3.5127.2, p < 0.001) [21] , a BMI above 50 (OR = 18.3, p < 0.001) [13] , tobacco use (OR = 12.76, 95%CI: 2.4766.16, p = 0.017) [23] , BMI below 20 (OR = 6.00, 95%CI: 1.230.9, p = 0.033) [21] , diabetes (OR = 5.47, 95%CI: 1.7716.97, p = 0.003) [26] , and coronary artery disease (OR = 5.10, 95%CI: 1.319.8, p = 0.017) [21] .
Modifiable risk factors
We further categorised the resultant risk factors into whether or not they were modifiable, reflecting the opportunity of the surgeon to optimise their patient pre operatively and to reduce the risk of developing a PJI ( Little is known about the interaction between, or synergistic effect, of specific patient risk factors [35] , as it is likely they have a multiplicity effect, rather than additive risk, as shown by Tomás [6] . In their cohort if a patient had two (or more) significant factors the probability of infection development was 14times higher, whereas having three (or more) factors the probability was increased 16times.
Several themes have emerged following this syste matic review of the literature, specifically the patient's immunological and systematic responses to infection, other sources of infection, antibiotic use, and provider factors.
Immunological response
The most frequently quoted risk factor was diabetes mellitus [4, 9, 17, 20, 22, 26] , which had one of the highest odds ratios [26] . Almost all the other highest odds ratio, or hazard ratio, also belonged to medical conditions ultimately impairing a patients immunity, as demonstrated from high dose preoperative steroids [21] , malnutrition (reflective of high alcohol intake [26] , BMI below 20 [21] and above 50 [13] ), and tobacco use [23] . Malignancy [4, 5] , rheumatoid arthritis [4, 15, 16] , and liver cirrhosis [28] can also impair a patient's immunity. Immunosuppression has long been known to increase a patient's risk of systemic infection, and has widely been documented in arthroplasty patients. Ragni et al [36] demonstrated this in human immunodeficiency virus positive hemophiliacs with CD4 counts of 200 mm 3 or less undergoing orthopaedic surgery. Postoperative infection occurred in 10 (15.1%) of 66 patients [36] . Local steroid injection causing focal immunosuppression about the joint has also been shown to increase the risk, compared to those that have not received any joint injections in hip arthroplasty cases [37] . In rheumatoid patients treated with immunosup pressive drugs (including biologic agents) undergoing all orthopeadic procedures, a statistically significant higher risk of infection was seen in this patient cohort compared to a degenerative/posttraumatic group (OR = 2.58, 95%CI: 1.913.48, p < 0.001) [38] . Furthermore this risk was significantly increased in patients taking multiple diseasemodifying antirheumatic drugs (DMARDs) (p = 0.036) or tumor necrosis factor α (TNFα) inhibitors (p = 0.032), especially if the last dose of TNFα inhibitor was given < 1 administration interval before surgery [38] .
Infection response
While not directed specifically to immunosuppression, other comorbidities have a role in reducing the patients systemic response to infection. Cardiac dysfunction [4, 16, 21] , renal failure [4, 15] , anaemia [4, 9, 16] and coagulopathy [16] have all been shown to increase the risk of infection. This may be directed through specific cellular pathways [39] , but may demonstrate the insult the surgical procedures has in causing a secondary inflammatory insults, worsening multiple organ dysfunction [40, 41] . Deranges in renal function, with progressively higher poor glomerular filtration rate (GFR) in either the acute or chronic stages, reduces the ability to remove unwanted and hazardous chemicals from the blood, and places the patient at a higher risk. Lieberman et al [42] demonstrated a high rates of infection in patients on chronic renal dialysis (19%), however in a separate patient series no significant increase in infection risk was seen [43] .
Infection source
We believe that if a patient is known to have systemic infection, or a localised infection but distant to the operative joint, the risk of haematological spread of infection to the implant is highly likely. We have demonstrated a statistically significant increased risk of PJI in patients with a pre operative confirmation of a genitourinary infection [10, 27] , nasal S. Aureus and MRSA infections [31] , or other distant organ infections [6] , such as hepatitis B [44] .
Conditions that further increase this risk are those that may make the patient more susceptible for the introduction of a new pathogen, such as chronic pulm onary disease [4, 31] with known high rates of pneumonia, peripheral vascular disease [4, 16] with high risk of skin ulceration and introduction of skin contaminates, and recent oesophagogastroduodenoscopy (EGD) with bio psy [22] , risking the introduction of gut flora to the blood system.
Furthermore, perioperative blood transfusion increases the risk of PJI in both hip and knee arthroplasty [11, 12, 15] , and allogeneic blood transfusion has been shown to instigate a detrimental immunomodulation reaction, and decreases Tcellmediated immunity, and may enhance the acute inflammatory response [45, 46] . Stored blood can cause a significant increase in inflammatory cytokine release from the stored neutrophils, and superoxide release results in delaying neutrophil apoptosis and risks cytotoxicity [47, 48] . This has been confirmed in a recent systematic metaanalysis of 6 studies demonstrating the association between allogeneic blood transfusion and an increased risk for a SSI after total hip and knee arthroplasty. Data was included from over 20000 patients, and the blood transfusion group had a significantly higher frequency of infection (pooled OR = 1.71, 95%CI: 1.232.40, p = 0.002) compared to the nonexposed group [49] .
Antibiotic use
The use of antibioticimpregnated cement was shown by Dale et al [18] to protect against revisions due to infection, whereas Namba et al [20] identified an increased risk.
Such conflicting outcomes are common in the literature regarding the use of antibioticimpregnated cement in primary procedures. A prospective randomized study with 2948 cemented total knee arthroplasties failed to see an improvement of PJI rates by using bone cement loaded with erythromycin and colistin compared to controls [50] , whereas the Norwegian Arthroplasty Register has demonstrated a synergistic effect of systemic and cement antibiotics [51] . However there is a general consensus that antibioticimpregnated cement has a greater role in revision cases [52] , and is recommended as standard practice in these highrisk cases [53] . Systemic antibiotics given at anaesthetic induction are generally the standard of care, and continued postoperatively for a further two doses in the United Kingdom, and for two days in Italy (authors experience). The choice of antibiotic varies in each Institute to reflect the prominent pathogen and patient cohort. Multiple studies have demonstrated the benefits of antibiotics given during the procedure to reduce the risk of post operative infection [51, 54] .
Provider factors
Concerning the relative impact of the hospitals yearly volume of procedures, we found only one retrospective review of joint registry data, that suggests that the fewer total knee arthroplasties undertaken per year will result in a lower rate of infection [20] . This particular finding needs, in our opinion, further validation, since it contradicts other reports demonstrating better outcomes from greater volumes of surgery and greater experience of the surgeons, as exemplified by the Hospital for Special Surgery, New York [55] , while other studies have shown no difference between the two [56] . Furthermore, the use of a drain postoperatively has been shown by Peel et al [15] to reduce the risk of PJI following knee arthroplasty, however multiple meta analyses and prospective, randomised, controlled trials have demonstrated no significant difference in post operative infections between the wounds treated with a drain and those without [57, 58] .
Modifiable risk factors
When the risk factors were further categorised into modifiable or not, the vast majority of factors were nonmodifiable. Many risk factors increased a patient's risk by less than 5 times (OR < 5), and very few increased the risk by more than 10 times. However, the presence of non-modifiable risk factors still requires attention, and may be more important than modifiable ones. Alternate methods should be adopted to reduce the patient's burden and may include a combination of implant modifications (such as silver or disposable microbiological coatings) [59, 60] , antibiotic impregnated cement or bone graft [61, 62] , or other novel therapies [63] to provide a personalized and more effective prophylaxis.
It is the responsibility of the operating team to act upon these, and modify or optimise the patient prior to surgery. For example, intensive insulin therapy, maintaining tight blood glucose concentrations between 80 and 110 mg/dL, has been shown to decrease infection related complications and mortality [64] . Normal renal function should be sought, nutrition improved, cardiac investigations and interventions should be offered, local and systemic infections appropriately treated, as should chronic anaemia, and patients should be informed to withhold DMARDs and stop tobacco smoking and alcohol use preoperatively.
Risk-analysis tools
Indeed, determining individual patients risks is an im portant step in personalized informed consent. Surgeons may quote published rates or their own, but the risk is individual and should reflect all the aforementioned factors, which may have consequences in the medico legal evaluation in case of damage evaluation after PJI.
Previous attempts to combine such measures in a scoring system have been attempted by The Mayo Clinic [65] who based the data on their cohort of patients at baseline and at one month. Bozic et al [35] developed a risk calculator using data from 11 years worth of Medicare claims. A similar tool has been developed in the Chinese population [26] . The main disadvantage of such tools is the cal culations relate to a specific set of patients, and may not reflect the general public risks, as they have not been externally validated. In addition the data is unlikely to appreciate advances in perioperative care over the time period, and may not capture patients with late onset PJI if followup is short.
Limitations
A wide variety of studies were included in this systematic review, which gives an overview of risk factors for hip and knee PJI but the quality of each study is generally poor. As previously discussed, only 8 studies (29.6%) were prospective, and one third of studies demonstrated record bias. Reporting bias was also seen amongst the studies, as a variety of diagnostic criteria were used. This is common amongst studies reviewing PJI as there is no gold standard measure to determine presence of infection, nor an agreement to the medical, or surgical management, for these patients [53] . Our search criteria only highlighted studies with "risk factor" in the title, and therefore we did not search for studies looking at individual risk factors. Therefore studies, some of high quality, may not have met our inclusion criteria. Furthermore, we were unable to undertake a meta analysis due to the heterogeneity of the data.
In conclusion, as demonstrated, current data is conflicting as the influence of the risk factors vary widely, and we believe more emphasis is required regarding the multiplicity effects of risk factors. We need larger studies and novel tools to investigate single and combined risk factors, and to identify key areas of improvement and modification for these patients.
The literature has demonstrated significant variation in the number and type of risk factors that places a patient at higher risk of developing a PJI, which is heavily weighted towards the patient. However the provider has a role in addressing the modifiable risk factors preoperatively to optimise their patient, and develop new strategies to limit the impact of non-modifiable factors.
coMMEntS
Background
Several studies have previously shown the impact of various risk factors on the probability of developing an infection after joint replacement. The heterogeneity of the available data notwithstanding, in this systematic review a detailed analysis of the respective weight of known risk factors, classified as host-, provider-or postsurgical-related, is performed; moreover, a further distinction in modifiable or notmodifiable risk factors is proposed.
Research frontiers
A classification and ranking of known risk factors may open new frontiers in prevention and control of peri-prosthetic infections. Furthermore, it can be helpful to improve the information to the patient prior to surgery, to drive personalised prophylaxis and to better evaluate the cost-to-benefit ratio of new technologies, like antibacterial coatings, designed to reduce bacterial adhesion on implanted biomaterials.
Innovations and breakthrough
This systematic review sheds new lights on the relative impact of various risk factors that increase a patient's risk of developing lower limb periprosthetic joint infections (PJI). This ultimately reiterates the importance of optimising the patients pre-operatively by addressing modifiable risk factors (such as their immunosuppression, nutrition, diabetes, and smoking), and develops strategies to limit the impact of non-modifiable factors.
Applications
The data obtained in this systematic review may form the basis for the development of specific software, like the "PJI Risk App", an application for smartphones, specifically designed to calculate the risk of developing a peri-prosthetic infection in a given patient. This in turn may be useful for surgeons and their patients to understand the specific risk of undergoing joint replacement and eventually to better tailor antibiotic prophylaxis.
Peer-review
In this manuscript authors reviewed provider risk factors of chronic PJI. This study is interesting and the objective very clear.
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